ArticlePloS one2026
Klotho levels and biological age acceleration: Insights from a diverse cohort of middle-aged and elderly individuals.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAging is characterized by progressive physiological and psychological changes, leading to decreased cellular metabolism and increased vulnerability to age-related diseases. METHODS.: In this study, we examined the relationship between circulating Klotho levels and biological age acceleration (BAA) in a representative cohort of middle-aged and older adults. Data were obtained from the National Health and Nutrition Examination Survey (NHANES, 2007-2010), including 5,654 participants aged 45-85 years. Serum Klotho concentrations were quantified using ELISA, while biological age was estimated with the BioAge R package.
resultLinear regression analyses demonstrated a robust inverse association between log-transformed Klotho levels and BAA across all statistical models, with reductions of -1.06 (95% CI: -1.77 to -0.36, p = 0.005), -1.44 (95% CI: -2.15 to -0.73, p < 0.001), and -1.30 (95% CI: -2.20 to -0.40, p = 0.01). Consistent results were observed in logistic regression models, where higher Klotho concentrations were linked to lower odds of accelerated aging (OR = 0.72, 95% CI: 0.59-0.88, p = 0.002; OR = 0.63, 95% CI: 0.51-0.77, p < 0.0001; OR = 0.62, 95% CI: 0.46-0.84, p = 0.01). Subgroup analyses revealed significant associations in women, participants over 60 years of age, and individuals without chronic illnesses. Interaction analyses further indicated that age (p-interaction = 0.002), alcohol intake (p-interaction = 0.04), and diabetes status (p-interaction = 0.03) significantly modified the Klotho-BAA relationship. Moreover, restricted cubic spline analysis showed a non-linear L-shaped dose-response pattern, suggesting that the protective effect of Klotho becomes more pronounced above a certain threshold.
conclusionCollectively, these findings underscore the pivotal role of Klotho in the biology of aging and emphasize the importance of accounting for demographic and health-related modifiers in future investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.